Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 18/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | KLK7 | P49862 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5263545 | 0.91 | GPR119 (0.57) | GPR119MAPK1 | |
| SCHEMBL1673981 | 0.89 | GPR119 (0.69) | GPR119MAPK1KDM4EUSP2ALDH1A1 | |
| SCHEMBL5263198 | 0.87 | GPR119 (0.57) | GPR119 | |
| SCHEMBL5265329 | 0.87 | GPR119 (0.57) | GPR119 | |
| SCHEMBL5264569 | 0.86 | GPR119 (0.57) | GPR119 | |
| SCHEMBL5263642 | 0.86 | GPR119 (0.54) | GPR119MAPK1KDM4EUSP2ALDH1A1 | |
| SCHEMBL5259810 | 0.85 | GPR119 (0.55) | GPR119 | |
| SCHEMBL5260172 | 0.85 | GPR119 (0.65) | GPR119 | |
| SCHEMBL5264940 | 0.84 | GPR119 (0.64) | GPR119 | |
| SCHEMBL5264420 | 0.83 | GPR119 (0.57) | GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599468-B1 | 1,2,3-TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO SUCH AS DIABETES AND HYPERGLYCEMIA | ARENA PHARM INC (US) | 2007-10-03 | — | — | EP | claimed |